Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TYR | P14679 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13410117 | 1.00 | MEN1 (0.33) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL13410140 | 0.95 | KDM4E (0.34) | MEN1TP53CYP3A4MAPTTSHR | |
| SCHEMBL12885218 | 0.95 | MEN1 (0.33) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL13410196 | 0.94 | KDM4E (0.32) | MEN1MAPTTSHRKMT2A | |
| SCHEMBL12893319 | 0.94 | LTB4R (0.37) | TP53MAPTALOX15KMT2AKCNH2 | |
| SCHEMBL10819415 | 0.93 | TYR (0.35) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL10164725 | 0.93 | TYR (0.35) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL18090329 | 0.93 | TYR (0.35) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL85811 | 0.93 | TYR (0.35) | MEN1TP53CYP3A4ALOX5MAPT | |
| SCHEMBL85810 | 0.93 | TYR (0.35) | MEN1TP53CYP3A4ALOX5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8222073-B2 | Fabricating TFT having fluorocarbon-containing layer | XEROX CORPORATION (US) | 2012-07-17 | — | — | US | disclosed |
| US-7834199-B2 | Small molecular thiophene compound having divalent linkage | XEROX CORPORATION (US) | 2010-11-16 | — | — | US | disclosed |
| US-7700787-B2 | Small molecular thiophene compound | XEROX CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-20080108833-A1 | SMALL MOLECULAR THIOPHENE COMPOUND | XEROX CORPORATION (US) | 2008-05-08 | — | — | US | disclosed |
| US-20080108834-A1 | SMALL MOLECULAR THIOPHENE COMPOUND HAVING DIVALENT LINKAGE | XEROX CORPORATION (US) | 2008-05-08 | — | — | US | disclosed |
| US-7312469-B2 | Device with small molecular thiophene compound | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070275501-A1 | FABRICATING TFT HAVING FLUOROCARBON-CONTAINING LAYER | XEROX CORPORATION (US) | 2007-11-29 | — | — | US | disclosed |
| US-7294850-B2 | Device with small molecular thiophene compound having divalent linkage | XEROX CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
| US-7282735-B2 | TFT having a fluorocarbon-containing layer | XEROX CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108834-A1 | SMALL MOLECULAR THIOPHENE COMPOUND HAVING DIVALENT LINKAGE | TST, AS3MT, TH | MEN1 2096/4885TP53 1156/4885CYP3A4 862/4885 |
| US-20080108833-A1 | SMALL MOLECULAR THIOPHENE COMPOUND | TST, ABCG2, TPMT | MEN1 2605/4885TP53 1042/4885CYP3A4 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.